These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 10872929

  • 1. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
    Krepler K, Kruger A, Tittl M, Stur M, Wedrich A.
    Retina; 2000; 20(3):251-6. PubMed ID: 10872929
    [Abstract] [Full Text] [Related]

  • 2. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
    Hassan AS, Johnson MW, Schneiderman TE, Regillo CD, Tornambe PE, Poliner LS, Blodi BA, Elner SG.
    Ophthalmology; 1999 Oct; 106(10):1900-6; discussion 1906-7. PubMed ID: 10519583
    [Abstract] [Full Text] [Related]

  • 3. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
    Auriol S, Mahieu L, Lequeux L, Quintyn JC, Pagot-Mathis V.
    J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910
    [Abstract] [Full Text] [Related]

  • 4. [Clinical results of intravitreal administration of tissue-type plasminogen activator (tPA) and gas for removal of subretinal hemorrhage in senile macular degeneration].
    Framme C, Toukhy HE, Sachs HG, Spiegel D, Roider J, Gabel VP, Lohmann CP.
    Klin Monbl Augenheilkd; 2000 Jan; 216(1):33-9. PubMed ID: 10702940
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
    Hay SR, Madonna RJ.
    Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129
    [Abstract] [Full Text] [Related]

  • 6. Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome.
    Schulze SD, Hesse L.
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):717-20. PubMed ID: 12271367
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of acute subretinal hemorrhage in age-related macular degeneration by combined intravitreal injection of recombinant tissue plasminogen activator and gas.
    Hesse L, Kroll P.
    Adv Ther; 1997 Sep; 14(5):275-80. PubMed ID: 10174620
    [Abstract] [Full Text] [Related]

  • 8. Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration.
    Fang IM, Lin YC, Yang CH, Yang CM, Chen MS.
    Eye (Lond); 2009 Feb; 23(2):397-406. PubMed ID: 17975562
    [Abstract] [Full Text] [Related]

  • 9. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
    Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC.
    Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of subretinal macular hemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas].
    Oficjalska-Młyńczak J, Zajac-Pytrus H, Marek J, Nizankowska MH.
    Klin Oczna; 2003 Jun; 105(3-4):140-6. PubMed ID: 14552171
    [Abstract] [Full Text] [Related]

  • 11. [Intravitreal injection of rt-PA and gas in the management of minor submacular haemorrhages secondary to age-related macular degeneration].
    Hattenbach LO, Brieden M, Koch F, Gümbel H.
    Klin Monbl Augenheilkd; 2002 Jul; 219(7):512-8. PubMed ID: 12195317
    [Abstract] [Full Text] [Related]

  • 12. Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study.
    Meyer CH, Scholl HP, Eter N, Helb HM, Holz FG.
    Acta Ophthalmol; 2008 Aug; 86(5):490-4. PubMed ID: 18221499
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.
    Mayer WJ, Hakim I, Haritoglou C, Gandorfer A, Ulbig M, Kampik A, Wolf A.
    Acta Ophthalmol; 2013 May; 91(3):274-8. PubMed ID: 21952010
    [Abstract] [Full Text] [Related]

  • 14. [Subretinal hematoma in age-related macular degeneration: treatment with intravitreal injection of tPA and gas].
    Leguay J, Gastaud P.
    J Fr Ophtalmol; 2000 Oct; 23(8):797-801. PubMed ID: 11033502
    [Abstract] [Full Text] [Related]

  • 15. Pneumatic displacement of submacular hemorrhage due to age-related macular degeneration.
    Ron Y, Ehrlich R, Axer-Siegel R, Rosenblatt I, Weinberger D.
    Ophthalmologica; 2007 Oct; 221(1):57-61. PubMed ID: 17183203
    [Abstract] [Full Text] [Related]

  • 16. Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator.
    Singh RP, Patel C, Sears JE.
    Br J Ophthalmol; 2006 Apr; 90(4):429-31. PubMed ID: 16547320
    [Abstract] [Full Text] [Related]

  • 17. Subretinal hemorrhages secondary to age-related macular degeneration: psychological and vision-related functional perspectives.
    Mozaffarieh M, Sacu S, Benesch T, Wedrich A.
    Ophthalmologica; 2008 Apr; 222(3):199-204. PubMed ID: 18497530
    [Abstract] [Full Text] [Related]

  • 18. Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration.
    Guthoff R, Guthoff T, Meigen T, Goebel W.
    Retina; 2011 Jan; 31(1):36-40. PubMed ID: 20921929
    [Abstract] [Full Text] [Related]

  • 19. [The intravitreal application of the tissue plasminogen activator in the treatment of submacular hemorrhage--a case report].
    Fric E, Sín M, Rehák M, Chrapek O, Simicák J, Fehák J.
    Cesk Slov Oftalmol; 2008 Nov; 64(6):237-40. PubMed ID: 19110965
    [Abstract] [Full Text] [Related]

  • 20. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC.
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.